Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation

Journal of the American College of Cardiology

Volumn 28, Issue 4, 1996, Pages 994-999

  Schmitt, Claus ^a   Alt, Eckhard ^a   Plewan, Andreas ^a   Ammer, Richard ^a   Leibig, Marcus ^a   Karch, Martin ^a   Schömig, Albert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEFIBRILLATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEMATOMA; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0030273140     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00274-4     Document Type: Article

References (34)

1. Alt E, Schmitt C, Ammer R, et al. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 1994;17(Pt II):1067-78.
2. Davidson E, Weinberger I, Rotenberger Z, Fuchs J, Agmon J. Atrial fibrillation: cause and time of onset. Arch Intern Med 1989;149:457-9.
3. Furberg CD, Psaty BM, Manolic TA, Jarden GM, Smith DE, Rautahariju PM, for the CHS Collaborative Research Group. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41.
4. Kerr CR. Atrial fibrillation: the next frontier. PACE 1994;17:1203-7.
5. Kistler JP. The risk of embolic stroke: another piece of the puzzle. N Engl J Med 1994;331:1517-9.
6. Coplen SE, Antman EM, Berkis JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation 1990;82:1106-16.
7. Lau C, Leung W. A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation. Am Heart J 1992;124:645-50.
8. Antman EM, Beamer AD Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol. 15:1990;698-707.
9. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527-32.
10. Singh S, Saini RV, DiMarco J, Kluger J, Gold R, Chen Y, and the Sotalol Study Group. Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. Am J Cardiol 1991;68:1227-30.
11. Juul-Möller S, Edvardsson N, Rhenqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990;82:1932-9.
12. Ewy GA. Optimal technique for electrical cardioversion of atrial fibrillation. Circulation 1992;86:1645-7.
13. Lown B, Perlroth MG, Kaidbey S, Abe T, Harken DE. Cardioversion of atrial fibrillation. N Engl J Med 1963;269:325-31.
14. Lundstrom T, Rydén L. Chronic atrial fibrillation: long-term results of direct current conversion. Acta Med Scand 1988;223:53-9.
15. Lèvy S, Lauribe P, Dolla E, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992;86:1415-20.
16. Nathan AW, Bexton RS, Spurrell RAJ, Camm AJ. Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias. Br Heart J 1984;52:377-84.
17. Kumagai K, Yamanouchi Y, Hiroki T, Arakawa K. Effects of transcatheter cardioversion on chronic lone atrial fibrillation. PACE 1991;14:1571-5.
18. Kumagai K, Yananouchi Y, Tashiro N, Hiroki T, Arakawa K Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dog. J Am Coll Cardiol. 16:1990;497-501.
19. Cooper RAS, Alferness CA, Smith WM, Ideker RE. Internal cardioversion of atrial fibrillation in sheep. Circulation 1993;87:1673-86.
20. Powell AC, Garan H, McGovern BA, Fallon JT, Krishnan SC, Ruskin JN Low energy conversion of atrial fibrillation in the sheep. J Am Coll Cardiol. 20:1992;707-711.
21. Alferness C, Ayers GM, Cooper RA, Ideker RE. Lead systems for atrial defibrillation. PACE 1994;17:1043-7.
22. Ideker RE, Wolf PD, Alferness CA, Krassowska W, Smith WM. Current concepts for selecting the location, size, and shape of defibrillation electrodes. PACE 1991;14:227-40.
23. Dunbar DN, Tobler HG, Fetter J, Gornick CC, Benson DW, Benditt DG. Intracavitary electrode catheter cardioversion of atrial tachyarrhythmias in the dog. J Am Coll Cardiol 1986;8:1015-27.
24. Murgatroyd FD, Slade AKB, Sopher M, Rowland E, Ward DE, Camm AJ. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995;25:1347-53.
25. Allessie MA, Konings K, Kirchhof C. Mapping of atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, editors. Atrial Fibrillation: Mechanisms and Therapeutic Strategies. Armonk, NY: Futura, 1994:37-49.
26. Rogers JM, McCulloch AD. A collocation-Galerkin finite element model of cardiac action potential propagation. IEEE Trans Biomed Eng 1994;41:743-57.
27. Spach MS, Miller WT, Dolber PC, Kootsey JM, Sommer JR, Mosher CE. The functional role of structural complexities in the propagation of depolarization in the atrium of the dog: cardiac conduction disturbances due to discontinuities of effective axial resistivity. Circ Res 1982;50:175-91.
28. Hohnloser S, Woosley RL. Drug therapy: sotalol. N Engl J Med 1994;331:31-8.
29. Hillsley RE, Wharton JM, Cates AW, Wolf PD, Ideker RE. Why do some patients have high defibrillation thresholds at defibrillator implantation? PACE 1994;17:222-39.
30. Jones JL, Jones RE, Balasky G. Microlesion formation in myocardial cells by high-intensity electric field stimulation. Am J Physiol 1987;253:H480-6.
31. Bardy GH, Allen MD, Mehra R, et al. Transvenous defibrillation in humans via the coronary sinus. Circulation 1990;81:1252-9.
32. Hillsley RE, Wharton JM. Implantable atrial defibrillators. J Cardiovasc Electrophysiol 1995;6:649-51.
33. Schmitt C, Ammer R, Plewan A.et al. Energy requirements for intracardiac low-energy atrial cardioversion: Comparison of different lead positions [abstract]. Circulation. 92(Suppl I):1995;I-473.
34. Levy S, Ricard P, Lau CPet al. Multicenter low energy transvenous atrial defibrillation (XAD) trial [abstract]. Circulation. 92(Suppl I):1995;I-472.